← Eichor
Condition: Essential Thrombocythemia Et Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Essential Thrombocythemia Et

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myel
Phase N/A · 2 location(s) · MPN Research Foundation · NCT07362225Phase 1/ Phase 2 Study to Assess Safety and Efficacy of Orally Administered JBI-802 in Subjects With Myeloproliferative
Phase 1/Phase 2 · 7 location(s) · Jubilant Therapeutics Inc. · NCT07612280Identification of MPN-specific Antigens and Anti-MPN TCRs in Myeloproliferative Neoplasm
Phase N/A · 1 location(s) · Université Catholique de Louvain · NCT07590986MethoTRExATE in MyelOpRolifErative Neoplasms (TREATMORE) Trial
Phase 2 · 1 location(s) · Icahn School of Medicine at Mount Sinai · NCT06541249National Longitudinal Cohort of Hematological Diseases
Phase N/A · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT04645199Peginterferon α-2b Injection for Hydroxyurea Resistant or Intolerant ET
Phase 2 · 8 location(s) · Xiamen Amoytop Biotech Co., Ltd. · NCT06552429Study of Pelabresib add-on to Ruxolitinib in Japanese Adult Patients With Myelofibrosis
Phase 1 · 7 location(s) · Novartis Pharmaceuticals · NCT07340138Extension Study of P1101 After Completion of Phase 2 Study in PV Patients or Phase 3 Study in ET Patients
Phase 3 · 6 location(s) · PharmaEssentia Japan K.K. · NCT04655092Efficacy and Safety of Peginterferon in ET and PV.
NA · 1 location(s) · Zhenya Hong · NCT06734637Reparixin in Patients With Myelofibrosis Myeloproliferative Neoplasms Research Consortium (MPN-RC 120)
Phase 2 · 9 location(s) · Icahn School of Medicine at Mount Sinai · NCT05835466Open Label Phase 1/2 Study of Tasquinimod in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibr
Phase 1/Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT06327100Mutant CALR-peptide Based Vaccine in Patients With Mutated CALR Myeloproliferative Neoplasm
Phase 1 · 1 location(s) · Marina Kremyanskaya · NCT05025488
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.